236 related articles for article (PubMed ID: 36071163)
1. Methotrexate recognition by the human reduced folate carrier SLC19A1.
Wright NJ; Fedor JG; Zhang H; Jeong P; Suo Y; Yoo J; Hong J; Im W; Lee SY
Nature; 2022 Sep; 609(7929):1056-1062. PubMed ID: 36071163
[TBL] [Abstract][Full Text] [Related]
2. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of antifolate recognition and transport by PCFT.
Parker JL; Deme JC; Kuteyi G; Wu Z; Huo J; Goldman ID; Owens RJ; Biggin PC; Lea SM; Newstead S
Nature; 2021 Jul; 595(7865):130-134. PubMed ID: 34040256
[TBL] [Abstract][Full Text] [Related]
4. Recognition of cyclic dinucleotides and folates by human SLC19A1.
Zhang Q; Zhang X; Zhu Y; Sun P; Zhang L; Ma J; Zhang Y; Zeng L; Nie X; Gao Y; Li Z; Liu S; Lou J; Gao A; Zhang L; Gao P
Nature; 2022 Dec; 612(7938):170-176. PubMed ID: 36265513
[TBL] [Abstract][Full Text] [Related]
5. The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.
Matherly LH; Wilson MR; Hou Z
Drug Metab Dispos; 2014 Apr; 42(4):632-49. PubMed ID: 24396145
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the expression of transcription factors and the reduced folate carrier as a novel mechanism of antifolate resistance in human leukemia cells.
Rothem L; Aronheim A; Assaraf YG
J Biol Chem; 2003 Mar; 278(11):8935-41. PubMed ID: 12519783
[TBL] [Abstract][Full Text] [Related]
7. Internalization of Methotrexate Conjugates by Folate Receptor-α.
Nogueira E; Sárria MP; Azoia NG; Antunes E; Loureiro A; Guimarães D; Noro J; Rollett A; Guebitz G; Cavaco-Paulo A
Biochemistry; 2018 Dec; 57(49):6780-6786. PubMed ID: 30452231
[TBL] [Abstract][Full Text] [Related]
8. Post-transcriptional regulation of the human reduced folate carrier as a novel adaptive mechanism in response to folate excess or deficiency.
Hou Z; Orr S; Matherly LH
Biosci Rep; 2014 Aug; 34(4):. PubMed ID: 24949876
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for recognition and transport of folic acid in mammalian cells.
Newstead S
Curr Opin Struct Biol; 2022 Jun; 74():102353. PubMed ID: 35303537
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective transport of human His27- and Arg27-reduced folate carrier.
Narawa T; Yanagisawa H; Itoh T
Biol Pharm Bull; 2014; 37(3):439-46. PubMed ID: 24583862
[TBL] [Abstract][Full Text] [Related]
11. Transport of folates and antifolates in liver.
Horne DW
Proc Soc Exp Biol Med; 1993 Apr; 202(4):385-91. PubMed ID: 8456101
[TBL] [Abstract][Full Text] [Related]
12. Renal conservation of folates role of folate transport proteins.
Damaraju VL; Cass CE; Sawyer MB
Vitam Horm; 2008; 79():185-202. PubMed ID: 18804695
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates.
Sierra EE; Goldman ID
Semin Oncol; 1999 Apr; 26(2 Suppl 6):11-23. PubMed ID: 10598550
[TBL] [Abstract][Full Text] [Related]
14. A humanized mouse model for the reduced folate carrier.
Patterson D; Graham C; Cherian C; Matherly LH
Mol Genet Metab; 2008 Feb; 93(2):95-103. PubMed ID: 17983788
[TBL] [Abstract][Full Text] [Related]
15. Biology of the major facilitative folate transporters SLC19A1 and SLC46A1.
Hou Z; Matherly LH
Curr Top Membr; 2014; 73():175-204. PubMed ID: 24745983
[TBL] [Abstract][Full Text] [Related]
16. Human reduced folate carrier: translation of basic biology to cancer etiology and therapy.
Matherly LH; Hou Z; Deng Y
Cancer Metastasis Rev; 2007 Mar; 26(1):111-28. PubMed ID: 17334909
[TBL] [Abstract][Full Text] [Related]
17. Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake.
Drori S; Jansen G; Mauritz R; Peters GJ; Assaraf YG
J Biol Chem; 2000 Oct; 275(40):30855-63. PubMed ID: 10899164
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of antifolate resistance.
Assaraf YG
Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
[TBL] [Abstract][Full Text] [Related]
19. Membrane transport of folates.
Matherly LH; Goldman DI
Vitam Horm; 2003; 66():403-56. PubMed ID: 12852262
[TBL] [Abstract][Full Text] [Related]
20. MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma.
Lau DT; Flemming CL; Gherardi S; Perini G; Oberthuer A; Fischer M; Juraeva D; Brors B; Xue C; Norris MD; Marshall GM; Haber M; Fletcher JI; Ashton LJ
Oncotarget; 2015 Jun; 6(17):15510-23. PubMed ID: 25860940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
